1 Alzheimer Suisse. Alzheimer et autres formes de démence en Suisse. 2022 [consulté le 07.10.2022]. Consultable sur:
https://www.alzheimer-schweiz.ch/fr/les-demences/article/alzheimer-et-autres-formes-de-demence-en-suisse
2 Giezendanner S, Monsch AU, Kressig RW, MuellerY, StreitS, Essig S, ZellerA, Bally K. (2019). General practitioners‘ attitudes towards early diagnosis of dementia: a cross-sectional survey. BMC Fam Pract. 2019;20(1):65.
3 Swiss Memory Clinics (SMC). Normes de qualité de contenu «Swiss Memory Clinics» applicables au diagnostic des démences. 2022 [consulté le 07.10.2022]. Consultable sur:
https://www.swissmemoryclinics.ch/fr/developpement-de-la-qualite/normes-de-qualite/diagnostic/
4 Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J Neuropathol Exp Neurol. 2012;71(4):266–73.
5 Palmqvist S, Tideman P, Cullen N, Zetterberg H, Blennow K; Alzheimer’s Disease Neuroimaging Initiative; et al. Prediction of future Alzheimer‘s disease dementia using plasma phospho-tau combined with other accessible measures. Nat Med. 2021;27(6):1034–42.
6 Popp J, Georgescu D, Bürge M, Mundwiler-Pachlatko E, Bernasconi L, Felbecker A. Biomarqueurs des pathologies neurodégénératives dans le diagnostic des troubles cognitifs. Revue et recommandations de Swiss Memory Clinics. Rev Med Suisse. 2022;8(808):2400–5.
7 Bürge M, Bieri G, Brühlmeier M, Colombo F, Demonet JF, Felbecker A,. Recommandations de Swiss Memory Clinics pour le diagnostic des démences. Praxis. 2018;107(8):435–51.
8 Hermann P, Zerr I. Rapidly progressive dementias – aetiologies, diagnosis and management. Nat Rev Neurol. 2022;18(6):363–76.
9 Geschwind MD. Rapidly Progressive Dementia. Continuum (Minneap Minn). 2016;22(2 Dementia):510–37.
10 Hermann P, Appleby B, Brandel JP, Caughey B, Collins S, Geschwind MD, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt- Jakob disease. Lancet Neurol. 2021;20,235–46.
11 Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021;92(7):757–68.
12 Banks SA, Sechi E, Flanagan EP. Autoimmune encephalopathies presenting as dementia of subacute onset and rapid progression. Ther Adv Neurol Disord. 2021;14:1756286421998906.
13 Dalmau J, Graus F. Antibody-Mediated Encephalitis. N Engl J Med. 2018;378(9):840–51.
14 Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F,, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045–57.
15 van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MA, et al. Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up. Neurology. 2016;87(14):1449–56.